Bioequivalence Study of CJ-30060 in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 9, 2018

Primary Completion Date

December 14, 2018

Study Completion Date

December 14, 2018

Conditions

Healthy Subjects

Interventions

DRUG

Exforge® tab 5/160mg, Crestor® tab 10mg

co-administration of Amlodipine 5mg/Valsartan 160mg(combination drug) and Rosuvastation 10mg

DRUG

CJ-30060 5/160/10mg

Fixed-dose combination drug containing Amlodipine 5mg and Valsartan 160mg and Rosuvastatin 10mg

Trial Locations (1)

RECRUITING

Korea University Anam Hospital, Seoul